Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

9.5%

2 terminated/withdrawn out of 21 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

19%

4 trials in Phase 3/4

Results Transparency

50%

8 of 16 completed trials have results

Key Signals

8 with results

Enrollment Performance

Analytics

N/A
11(52.4%)
Phase 3
4(19.0%)
Phase 1
3(14.3%)
Phase 2
3(14.3%)
21Total
N/A(11)
Phase 3(4)
Phase 1(3)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT04886739Phase 2Completed

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea

Role: collaborator

NCT06930209Not ApplicableActive Not Recruiting

Histological Analysis of CelluJuve® Injections in the Brachium

Role: collaborator

NCT05320393Phase 2Completed

Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines

Role: collaborator

NCT03521804Not ApplicableTerminated

Safety and Efficacy Study of the SoundBite™ Crossing System With ACTIVE Wire in Coronary CTOs.

Role: collaborator

NCT03933657Not ApplicableWithdrawn

Prospective Study of the SoundBite™ Crossing System in Complex Peripheral CTOs

Role: collaborator

NCT03880058Phase 1Completed

Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

Role: collaborator

NCT05430464Not ApplicableUnknown

A Study of a Laser for the Treatment of Acne Vulgaris

Role: collaborator

NCT00630812Phase 3Completed

Long Term Administration of Inhaled Mannitol in Cystic Fibrosis

Role: collaborator

NCT04508205Phase 1Completed

CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes

Role: collaborator

NCT04508660Phase 1Completed

CGB-400 for the Reduction of Facial Redness

Role: collaborator

NCT02642627Not ApplicableCompleted

The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area

Role: collaborator

NCT01559922Phase 3Completed

Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction

Role: collaborator

NCT02643628Not ApplicableCompleted

A Pilot Study to Evaluate the Safety and Effectiveness of Microneedling and Bellafill to Treat Facial Acne Scars

Role: collaborator

NCT02679456Phase 2Completed

Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

Role: collaborator

NCT03817164Not ApplicableUnknown

Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis

Role: collaborator

NCT03266835Not ApplicableCompleted

SoundBite™ Crossing System Pivotal Peripheral CTO Crossing Study

Role: collaborator

NCT03511755Not ApplicableCompleted

12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN

Role: collaborator

NCT02195427Not ApplicableCompleted

TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds

Role: collaborator

NCT02253147Not ApplicableCompleted

TEOSYAL® RHA Ultra Deep and Perlane-L® for the Correction of Nasolabial Folds

Role: collaborator

NCT01091727Phase 3Completed

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Role: collaborator